任意の製品分析
許可いただいた場合、プライバシーに配慮した限定的な分析を使用し、どのリサーチ経路が有効かを把握します。広告トラッカーやセッション録画は使用しません。この選択は設定で変更できます。詳しくは プライバシーポリシー.
Celanese Corporation's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $5.2B | |
|---|---|---|
| Revenue (ttm) | 9.7B | |
| Net income (ttm) | -1.2B | |
| EPS (ttm) | -$10.7 | |
| Shares out | 109.7M | |
| P/E (forward) | 7.2x | |
| Dividend | $0.12 (0.25%) | |
| Volume | 699,949 | |
| Beta | 0.76 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $8.54B | $9.67B | $10.93B | $10.27B | $9.54B | +2.8% |
| Gross profit | $2.68B | $2.38B | $2.58B | $2.34B | $1.95B | -7.6% |
| Operating income | $1.95B | $1.38B | $1.67B | $-720.0M | $-786.0M | — |
| Net income | $1.89B | $1.89B | $1.94B | $-1.54B | $-1.17B | — |
| EPS (diluted) | $16.86 | $17.34 | $17.76 | $-14.11 | $-10.64 | — |
| EBITDA | $2.72B | $2.30B | $2.61B | $503.0M | $335.0M | -40.7% |
| R&D | $86.0M | $112.0M | $146.0M | $130.0M | $125.0M | +9.8% |
| SG&A | $633.0M | $824.0M | $1.08B | $1.03B | $899.0M | +9.2% |
Recent company headlines from major financial publishers.
Global industrial demand and automotive assembly rates rebound robustly, driving strong volume growth for Engineered Materials. Acetyl Chain pricing remains elevated as Western Hemisphere supply chain advantages persist. Rapid debt retirement reduces annual interest expense, accelerating EPS growth and unlocking multiple expansion toward historical peak levels.
Celanese executes on its core operational strategy: modest revenue growth, steady recovery in Engineered Materials margins via footprint actions, and resilient cash generation from the Acetyl Chain. Free cash flow is disciplined and deployed exclusively to debt reduction, steadily lowering financial leverage and driving intrinsic value convergence to $76.31.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 7.4% | $83.4 | $85.8 | $88.3 | $91.2 | $94.3 |
| 7.9% | $77.7 | $79.7 | $81.8 | $84.2 | $86.7 |
| 8.4% | $72.9 | $74.5 | $76.3 | $78.2 | $80.3 |
| 8.9% | $68.7 | $70.1 | $71.6 | $73.2 | $74.9 |
| 9.4% | $64.9 | $66.1 | $67.4 | $68.8 | $70.3 |
Upcoming earnings date and setup when available.
各月に公開されたリサーチ版が示したレーティングです。レーティングは分析時点の株価を公正価値と比較したもので、判断が当たったかどうかの記録ではありません。
| 年 | 1月 | 2月 | 3月 | 4月 | 5月 | 6月 | 7月 | 8月 | 9月 | 10月 | 11月 | 12月 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |